pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 30·1 min read
save

J. Craig Venter, pioneering genomics scientist, dies at 79 after cancer treatment

Apr 30, 2026·read at STAT ↗Positive

J. Craig Venter, a leading figure in genomics, passed away at age 79. The cause was complications from a cancer treatment.

Venter’s work helped turn genetics from a craft into an industrial information platform, famously racing a government project to sequence the first human genome and drawing worldwide attention.

He also led unconventional ventures, such as sailing to collect marine genetic data and creating a synthetic bacterium by removing its natural genome and rebuilding it from synthesized genes.

While some scientists saw him as a profit‑driven entrepreneur and some businesspeople viewed him as a reckless scientist, Venter saw his role as using business tools to advance science, leaving a lasting impact on biotech.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood”

read at STAT ↗
1,585 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
MOUNTAIN2Millennium Pharmaceuticals Inc2LEADINGNational Institutes of HealthPFIZER
drugs
Obesity
topics
Cardiology6Oncology2Ophthalmology2Diagnostics CompanyObesityVaccines

related stories

  • Sep 15Businesses can now apply for NIH fundingSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Dec 22Fierce Biotech Fundraising Tracker '26: Estuary channels $93M series A; OMass obtains $310MFierce Biotech
  • 4d agoNew study examines GLP-1 impact on interactions with criminal justice system, employment, housing stabilitySTAT
  • Aug 18STAT+: A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle massSTAT